DSIP
L-tryptophyl-L-alanyl-glycyl-glycyl-L-aspartyl-L-alanyl-L-seryl-glycyl-L-glutamic acid
DSIP is a naturally occurring nonapeptide identified in 1977 from rabbit cerebral venous blood, comprising nine amino acids in the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. This linear, hydrophilic peptide maintains its endogenous structure without synthetic modifications, making it ideal for sleep regulation research, stress response modulation, and central nervous system function studies in controlled experimental settings.
Complete Dosing Guide
What is DSIP?
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide consisting of nine amino acids that was first discovered in 1974. It plays a role in regulating sleep patterns, particularly in promoting deep, restorative sleep and managing the sleep-wake cycle. DSIP also influences pain perception, stress response, and withdrawal symptoms from certain substances.
When is DSIP Used?
Sleep Disorders:
- Management of chronic insomnia
- Improvement of sleep quality and efficiency
- Normalization of disrupted sleep patterns
- Reduction of sleep onset time
Pain Management:
- Chronic pain episodes including migraines
- Vasomotor headaches
- Tinnitus-related discomfort
- Psychogenic pain syndromes
Substance Withdrawal:
- Opioid withdrawal symptoms (97% success rate reported)
- Alcohol withdrawal symptoms (87% success rate reported)
- Management of detoxification processes
Stress and Mood:
- Stress reduction and management
- Mood stabilization in depressive states
- Regulation of stress hormones
Medical Disclaimer
DSIP is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.